Literature DB >> 2187808

Nonimmune binding of human immunoglobulin A to type II group B streptococci.

B F Anthony1, N F Concepcion, S M Puentes, N R Payne.   

Abstract

The binding of 125I-labeled human myeloma immunoglobulin A (IgA) to four type II strains and one nontypable strain of group B streptococci was measured after streptococcal chains were broken by brief sonication. Some IgA binding was observed with all strains, but specific binding (binding that was inhibited by excess unlabeled IgA, was dose dependent, and was saturable) occurred only with those strains possessing the trypsin-sensitive beta component of the c protein. Similar amounts of binding were observed with myeloma IgA and IgA1 purified from normal serum. Specific binding was more rapid at 25 degrees C than at 0 or 37 degrees C and reached a plateau in 6 to 8 h. Binding was drastically reduced (85 to 90%) when streptococci had been heated (90 degrees C for 1 h). Most radioactivity bound to group B streptococci could be displaced (greater than 60% in 3 days) by the addition of excess unlabeled IgA. The binding capacity of one strain (10(8) streptococci in 1 ml of buffer) was saturated by approximately 24 micrograms of IgA. When transformed for Scatchard analysis, these data indicated that there was a specific binding capacity of 16,000 molecules of monomeric serum IgA per single streptococcal cell. The dissociation constant for IgA binding was 19.3 nM. Since enzyme-linked immunosorbent assay studies showed that the myeloma IgA used for the studies described above was IgA1, our quantitative data apply only to the binding of this subclass to group B streptococci. However, an enzyme-linked immunosorbent-filtration assay showed that both IgA1 and IgA2 bound to a type II group B streptococcus bearing the c protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187808      PMCID: PMC258724          DOI: 10.1128/iai.58.6.1789-1795.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Complete and incomplete Ibc protein fraction in group B streptococci.

Authors:  L Bevanger; J A Maeland
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-02

2.  Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay.

Authors:  L J Brady; U D Daphtary; E M Ayoub; M D Boyle
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

3.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

4.  A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum.

Authors:  M A Markwell
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

5.  Separation of human IgA1 and IgA2 using jacalin-agarose chromatography.

Authors:  R L Gregory; J Rundegren; R R Arnold
Journal:  J Immunol Methods       Date:  1987-05-04       Impact factor: 2.303

6.  Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.

Authors:  B F Anthony
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

7.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  Analysis of group B streptococcal types associated with disease in human infants and adults.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

9.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

10.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  5 in total

1.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

Authors:  L C Madoff; L C Paoletti; J Y Tai; D L Kasper
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

3.  Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides.

Authors:  H Schroten; C Stapper; R Plogmann; H Köhler; J Hacker; F G Hanisch
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 4.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

5.  Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets.

Authors:  Leona Raskova Kafkova; Diana Brokesova; Michal Krupka; Zuzana Stehlikova; Jiri Dvorak; Stepan Coufal; Alena Fajstova; Dagmar Srutkova; Katerina Stepanova; Petra Hermanova; Renata Stepankova; Ivo Uberall; Jozef Skarda; Zdenek Novak; Luca Vannucci; Helena Tlaskalova-Hogenova; Zuzana Jiraskova Zakostelska; Marek Sinkora; Jiri Mestecky; Milan Raska
Journal:  Mucosal Immunol       Date:  2020-09-24       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.